Venclyxto (venetoclax) in combination with Hypomethylating Agents (HMAs) or Low Dose Cytarabine (LDAC) for the treatment of adult patients with newly-diagnosed acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy.

MedNytt - Metodevarsling for helsetjenesten
(/mednytt/legemidler/venclyxto-venetoclax-in-combination-with-hypomethylating-agents-hmas-or-low-dose-cytarabine-ldac-for-the-treatment-of-adult-patients-with-newly-diagnosed-acute-myeloid-leukaemia-aml-who-are-ineligible-for-intensive-chemotherapy)